Boston, MA, United States of America

Susan Ghiassian

USPTO Granted Patents = 2 

Average Co-Inventor Count = 3.1

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2023-2024

Loading Chart...
2 patents (USPTO):

Title: Susan Ghiassian: Innovator in Autoimmune Disease Treatment

Introduction

Susan Ghiassian is a prominent inventor based in Boston, MA (US), known for her significant contributions to the field of autoimmune disease treatment. With a focus on developing alternative therapies, she has been instrumental in advancing medical technology through her innovative approaches.

Latest Patents

Susan Ghiassian holds 2 patents that showcase her expertise in treating autoimmune conditions. Her latest patents include "Methods of treating a subject with an alternative to anti-TNF therapy," which outlines a novel approach for patients suffering from autoimmune diseases. Another significant patent is "Methods of treating a subject suffering from rheumatoid arthritis with alternative to anti-TNF therapy based in part on a trained machine learning classifier." This patent presents systems and methods for developing classifiers that predict patient responses to specific treatments, enhancing the effectiveness of therapeutic interventions.

Career Highlights

Throughout her career, Susan has made remarkable strides in the medical field, particularly in the development of alternative therapies for autoimmune disorders. Her work has not only contributed to scientific knowledge but has also paved the way for improved patient outcomes.

Collaborations

Susan collaborates with notable professionals in her field, including Keith J Johnson and Theodore R Mellors. These partnerships have further enriched her research and innovation efforts.

Conclusion

Susan Ghiassian's work exemplifies the impact of innovation in healthcare, particularly in the treatment of autoimmune diseases. Her patents and collaborative efforts continue to influence the medical community and improve patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…